[VRTX] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
28-Jul-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -92.74%
YoY- 127.89%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 1,524,485 941,293 752,157 544,135 431,608 166,076 138,421 49.10%
PBT 824,770 327,138 216,591 35,506 -18,021 -190,861 -158,689 -
Tax -12,500 59,711 10,341 4,337 18,130 30,131 693 -
NP 837,270 267,427 207,360 17,996 -64,525 -188,848 -159,382 -
Tax Rate 1.52% -18.25% -4.77% -12.21% - - - -
Total Cost 687,215 673,866 544,797 526,139 496,133 354,924 297,803 14.94%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 54.92 28.41 27.57 3.31 -14.95 -113.71 -115.14 -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS 3.22 1.04 0.82 0.07 -0.26 -0.78 -0.68 -
EPS Diluted 3.18 1.03 0.80 0.07 -0.26 -0.78 -0.68 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.